USFDA28 Sept 2026, 06:10 pm
Zydus Lifesciences Ahmedabad Plant USFDA Inspection Concludes
AI Summary
Zydus Lifesciences announced the conclusion of a USFDA cGMP inspection at its manufacturing plant in SEZ II, Ahmedabad. The inspection, conducted from September 21st to 28th, 2026, resulted in a single observation. Importantly, there were no data integrity-related observations. The company stated it will work closely with the USFDA to address the observation promptly. This disclosure is made pursuant to SEBI regulations.
Key Highlights
- USFDA inspection at Zydus' Ahmedabad plant concluded.
- Inspection period: September 21-28, 2026.
- One observation noted, no data integrity issues.
- Company to address observation expeditiously.
Price Impact
More from ZYDUSLIFE